HYBRID EVENT: You can participate in person at Rome, Italy or Virtually from your home or work.
Supply Chain Developments
All stakeholders involved in the drug manufacturing and distribution process, from raw materials to patients, compose the pharmaceutical supply chain. The pharmaceutical supply chain has its own set of problems to deal with. Pharmaceutical industries must handle the most prevalent issues in the pharmaceutical supply chain in order to get patients their needed pharmaceuticals as quickly as possible. Manufacturers, wholesale distributors, and pharmacy benefit managers are among the many parties involved in the pharmaceutical supply chain (PBM). Pharmaceutical companies have a lot of impact on this complicated process.
- Changes in Pharma Supply Chains
- COVID-19 Effect on Supply chains
- Pharmaceutical Supply Chain and Drug Costs
Submit your abstract Today
Title : Engineered nanomaterial-mediated systemically administered m-RNA-based gene therapy directed exclusively to cancer, present successes and future prospects
A C Matin, Stanford University, United States
Title : Preparation and characterization of fibers made from PCL/PVP-ChAgG, along with exploring their potential as wound dressings
Luis Jesus Villarreal Gomez, Autonomous University of Baja California, Mexico
Title : Liver biopsy handling of metabolic-associated fatty liver disease (mafld): The children's hospital of eastern ontario grossing protocol
Consolato M Sergi, University of Ottawa, Canada
Title : Haptoglobin-related protein without signal peptide as biomarker of renal salt wasting (HPRWSP) in hyponatremia, hyponatremia-related diseases and as new syndrome in alzheimer’s disease
John K Maesaka, NYU Langone Hospital Long Island, United States